Your search returned 2 results.

Results
	1.	Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial. MedStar authors: Waksman, Ron PMID: 26470647 Year: 2016 Citation: Lancet. 387(10013):31-9, 2016 Jan 2. Institution: MedStar Heart & Vascular Institute Medline publication type: Clinical Study Journal Article Multicenter Study Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Abizaid A, Christiansen EH, Eeckhout E, Escaned J, Garcia-Garcia HM, Haude M, Ince H, Kaiser C, Lemos PA, Lim ST, Neumann FJ, Toelg R, von Birgelen C, Waksman R, Wijns W DOI: http://dx.doi.org/10.1016/S0140-6736(15)00447-X Add to cart (remove)
	2.	Bioresorbable drug-eluting magnesium-alloy scaffold: design and feasibility in a porcine coronary model. MedStar authors: Waksman, Ron PMID: 23680959 Year: 2013 Citation: Eurointervention. 8(12):1441-50, 2013 Apr 22. Institution: MedStar Heart & Vascular Institute Medline publication type: Comparative Study Journal Article Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Adden N, Braune M, Riedmuller J, Savard C, Waksman R, Wittchow E DOI: http://dx.doi.org/10.4244/EIJV8I12A218 Add to cart (remove)

Refine your search